Prostaglandin E(2) at new glance : Novel insights in functional diversity offer therapeutic chances

Legler, Daniel; Bruckner, Markus; Uetz-Allmen, Edith; Krause, Petra

Prostaglandin E(2) at new glance : Novel insights in functional diversity offer therapeutic chances

Files

Legler_opus-106237.pdf(224.92 KB)

Date

2009

Authors

Legler, Daniel

Bruckner, Markus

Uetz-Allmen, Edith

Krause, Petra

Publication type

Journal article

Published in

The International Journal of Biochemistry & Cell Biology ; 42 (2009), 2. - pp. 198-201. - ISSN 1357-2725. - eISSN 1878-5875

Abstract

Prostaglandin E2 (PGE2) is the most abundant eicosanoid and a very potent lipid mediator. PGE2 is produced predominantly from arachidonic acid by its tightly regulated cyclooxygenases (COX) and prostaglandin E synthases (PGES). Secreted PGE2 acts in an autocrine or paracrine manner through its four cognate G protein coupled receptors EP1 to EP4. Under physiological conditions, PGE2 is key in many biological functions, such as regulation of immune responses, blood pressure, gastrointestinal integrity, and fertility. Deregulated PGE2 synthesis or degradation is associated with severe pathological conditions like chronic inflammation, Alzheimer's disease, or tumorigenesis. Therefore, pharmacological inhibition of COX enzymes and PGE2 receptor antagonism is of great therapeutic interest.

Subject (DDC)

570 Biosciences, Biology

Cite This

ISO 690

LEGLER, Daniel, Markus BRUCKNER, Edith UETZ-ALLMEN, Petra KRAUSE, 2009. Prostaglandin E(2) at new glance : Novel insights in functional diversity offer therapeutic chances. In: The International Journal of Biochemistry & Cell Biology. 42(2), pp. 198-201. ISSN 1357-2725. eISSN 1878-5875. Available under: doi: 10.1016/j.biocel.2009.09.015

BibTex

@article{Legler2009Prost-3303,
  year={2009},
  doi={10.1016/j.biocel.2009.09.015},
  title={Prostaglandin E(2) at new glance : Novel insights in functional diversity offer therapeutic chances},
  number={2},
  volume={42},
  issn={1357-2725},
  journal={The International Journal of Biochemistry & Cell Biology},
  pages={198--201},
  author={Legler, Daniel and Bruckner, Markus and Uetz-Allmen, Edith and Krause, Petra}
}

RDF

<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/3303">
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:bibliographicCitation>Publ. in: The International Journal of Biochemistry &amp; Cell Biology 42 (2010), 2, pp. 198-201</dcterms:bibliographicCitation>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-23T10:19:58Z</dc:date>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/3303"/>
    <dcterms:title>Prostaglandin E(2) at new glance : Novel insights in functional diversity offer therapeutic chances</dcterms:title>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-23T10:19:58Z</dcterms:available>
    <dc:creator>Krause, Petra</dc:creator>
    <dc:contributor>Legler, Daniel</dc:contributor>
    <dc:creator>Legler, Daniel</dc:creator>
    <dc:contributor>Bruckner, Markus</dc:contributor>
    <dc:contributor>Krause, Petra</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <dcterms:abstract xml:lang="deu">Prostaglandin E2 (PGE2) is the most abundant eicosanoid and a very potent lipid mediator. PGE2 is produced predominantly from arachidonic acid by its tightly regulated cyclooxygenases (COX) and prostaglandin E synthases (PGES). Secreted PGE2  acts in an autocrine or paracrine manner through its four cognate G protein coupled receptors EP1 to EP4. Under physiological conditions, PGE2 is key in many biological functions, such as regulation of immune responses, blood pressure, gastrointestinal integrity, and fertility. Deregulated PGE2 synthesis or degradation is associated with severe pathological conditions like chronic inflammation, Alzheimer's disease, or tumorigenesis. Therefore, pharmacological inhibition of COX enzymes and PGE2 receptor antagonism is of great therapeutic interest.</dcterms:abstract>
    <dc:language>eng</dc:language>
    <dc:contributor>Uetz-Allmen, Edith</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/3303/1/Legler_opus-106237.pdf"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Bruckner, Markus</dc:creator>
    <dcterms:issued>2009</dcterms:issued>
    <dc:creator>Uetz-Allmen, Edith</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/3303/1/Legler_opus-106237.pdf"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/>
  </rdf:Description>
</rdf:RDF>